Artiva Biotherapeutics, Inc.ARTV
Price (close)
$6.99
Market cap
$341.7M
P/E
—
Revenue (TTM)
$0
Net income
-$90.8M
Dividend yield
—
1-year total return
132.2%
Net margin
—
Revenue growth
—
Debt / equity
—
What Artiva Biotherapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | $33.5M | $251,000 | $0 |
| Net income | — | -$28.7M | -$65.4M | -$83.9M |
| Free cash flow | — | -$50.7M | -$55.7M | -$79.3M |
More on ARTV.
- Artiva Biotherapeutics, Inc. summary
- Artiva Biotherapeutics, Inc. financial statements
- Artiva Biotherapeutics, Inc. key metrics
- Artiva Biotherapeutics, Inc. health scores and style box
- Artiva Biotherapeutics, Inc. earnings
- Artiva Biotherapeutics, Inc. dividends
- Artiva Biotherapeutics, Inc. valuation
- Artiva Biotherapeutics, Inc. ownership and insiders
- Artiva Biotherapeutics, Inc. peers
Figures from Artiva Biotherapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.